Osamu Itakura
Hokkaido University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Osamu Itakura.
British Journal of Haematology | 1997
Hideaki Kikuta; Osamu Itakura; Koji Taneichi; Michifumi Kohno
Multicentric Castlemans disease (MCD), also called multicentric angiofollicular lymphoid hyperplasia, is a systemic lymphoproliferative disorder causing fever, lymphadenopathy and splenomegaly. Recently, Kaposis sarcoma‐associated herpesvirus/human herpesvirus 8 (KSHV/HHV‐8) DNA sequences have been detected in cases of MCD. We examined HHV‐8 DNA sequences in the peripheral blood mononuclear cells (PBMCs) of two HIV‐negative patients with MCD and in PBMCs and the lymph node of a HIV‐negative patient with localized Castlemans disease (LCD) by the polymerase chain reaction. The novel sequences were detected in all DNA samples. Furthermore, the sequences were detected in only the CD19+ B‐lymphocyte fraction of the patient with LCD as previously reported. However, the sequences were detected in CD19+ B‐lymphocyte and CD2+ T‐lymphocyte fractions of two patients with MCD. These results suggest that HHV‐8 has tropisms for both B lymphocytes and T lymphocytes in Castlemans disease.
Archives of Disease in Childhood | 1998
Mitsuo Narita; Yoshihiro Matsuzono; Osamu Itakura; Satoshi Yamada; Takehiro Togashi
Ten pediatric patients with mycoplasmal pleuritis were tested for the presence of Mycoplasma pneumoniae in pleural fluid by the polymerase chain reaction (PCR). Three of the four PCR positive cases left a persistent consolidation. The remaining one was an infant who required mechanical ventilation. PCR may be useful in predicting delayed resolution of roent- genographic abnormality.
Clinical and Diagnostic Virology | 1997
Mitsuo Narita; Satoshi Yamada; Yoshihiro Matsuzono; Osamu Itakura; Takehiro Togashi; Hideaki Kikuta
BACKGROUND While many previous studies have focused on the impairment in the cellular immunity during measles virus infection, to date, a limited amount of data is available concerning the virus-specific IgG subclass response during measles virus infection. OBJECTIVE The purpose of this study is to analyze the measles virus infection on the basis of virus-specific IgG subclass (G 1 and G 3). STUDY DESIGN Frozen-stored, serum and/or cerebospinal fluid samples from three groups of patients were tested retrospectively; Group 1 comprised 14 patients with measles primary infection, group 2, ten patients with reinfection/vaccine failure, and group 3, seven patients with subacute sclerosing panencephalitis. The method used was a modified ELISA method utilizing the Enzygnost IgG detection kit with mouse-monoclonal antibodies (clone HP6091 for IgG 1 and clone HP6050 for IgG 3). Avidity testing for each subclass IgG was also performed for selected samples by means of an 8 M urea-denaturation method. RESULTS In group 1, the IgG 3 could be detected in serum within 7 days from the onset of rash more frequently than IgG 1. In the cases of group 2, both subclasses were detected in very acute phase serum samples. In these cases, the IgG 1-specific avidity was always higher than that of IgG 3. In group 3, the subclass IgGs detected in the cerebrospinal fluid had a lower avidity than those in the serum. CONCLUSIONS Our results suggested that in measles virus infection, like other viral infections, the IgG 3 response normally occurs before the IgG 1 response, and plays a major role in the acute phase immunity during the primary infection, while the IgG 1 plays a major role in the maintenance of immunity. Continuously produced IgG 1 and IgG 3 in the central nervous system in cases of subacute sclerosing panencephalitis may be derived from cell populations different from those in the blood.
Clinical Infectious Diseases | 2001
Akiko Okamura; Osamu Itakura; Mikio Yoshioka; Mitsuru Kubota; Hideaki Kikuta; Kunihiko Kobayashi
The typical clinical presentation of measles in a normal immunocompetent host includes cough, coryza, conjunctivitis, Kopliks spots, and rash. However, in an immunocompromised host, measles may have an atypical clinical presentation and may be commonly associated with severe pneumonia or encephalitis. We report a fatal case of measles pneumonia without any clinical features that suggest measles in a patient with acquired immunodeficiency syndrome.
Pediatrics International | 2000
Akira Ehara; Kiyoshi Egawa; Fumiko Kuroki; Osamu Itakura; Masahito Okawa
Abstract Background: The aim of the present study was to determine the relationship between the expression of abdominal symptoms and the age of patients with Yersinia enterocolitica infections.
Pediatrics International | 1995
Yoshihiro Matsuzono; Mitsuo Narita; Akira Satake; Takehiro Togashi; Osamu Itakura; Kunio Ozutsumi; Masahiro Iguchi
Secondary vaccine failure (SVF) of measles is generally believed to run a milder course of illness than an ordinary course of infection. Severe complications such as central nervous system involvement have rarely been reported. A 12 year old girl, who had received a live attenuated measles vaccine 10 years earlier, developed an encephalomyelitis in the absence of symptoms indicative of ordinary measles such as Koplik spots. Anti‐measles hemagglutination inhibition (HI) titer and measles IgM and IgG anitbody titers were measured in a commercial laboratory. Measles virus genomic sequence was detected by polymerase chain reaction. Both serum and cerebrospinal fluid (CSF) samples obtained at acute phase already showed extremely high titers of HI (x 8192 in serum and x 1024 in CSF, respectively) and IgG antibody along with the presence of IgM antibody. Polymerase chain reaction detected the measles virus genomic sequence in the acute phase CSF. The patients definite history of measles vaccination, high titers of HI and IgG antibodies observed at the very early stage of illness and the clinical course indicated that this patient had an encephalomyelitis due to SVF of measles. It is suggested that measles virus can be a pathogen of encephalitis without symptoms indicative of ordinary measles in individuals who received live attenuated measles vaccines.
Clinical and Vaccine Immunology | 1998
Mitsuo Narita; Yoshihiro Matsuzono; Yasuo Takekoshi; Satoshi Yamada; Osamu Itakura; Mitsuru Kubota; Hideaki Kikuta; Takehiro Togashi
Pediatric Infectious Disease Journal | 1995
Mitsuo Narita; Osamu Itakura; Yoshihiro Matsuzono; Takehiro Togashi
Clinical Infectious Diseases | 1996
Mitsuo Narita; Yoshihiro Matsuzono; Osamu Itakura; Takehiro Togashi; Hideaki Kikuta
Clinical and Vaccine Immunology | 1996
Mitsuo Narita; Satoshi Yamada; Yoshihiro Matsuzono; Osamu Itakura; Takehiro Togashi; Hideaki Kikuta